Juniper Biomedical Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 2

Employees

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $1.6M

  • Investors
  • 10

Juniper Biomedical General Information

Description

Developer of implantable neuromodulation systems designed to effectively and safely treat patients with pelvic health conditions. The company's technology modulates distal target nerves locally by stimulating only the target and can be used to modulate innervation to muscles or organs alike, enabling patients to avail less invasive, safer, and effective therapy for conditions like incontinence, sexual dysfunction, and chronic pain.

Contact Information

Website
www.juniperbiomedical.com
Formerly Known As
RBI Medical
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • UMASS Medical School
  • 55 Lake Avenue North
  • Worcester, MA 01655
  • United States
+1 (617)
Primary Industry
Therapeutic Devices
Other Industries
Biotechnology
Vertical(s)
Digital Health, HealthTech, Life Sciences
Corporate Office
  • UMASS Medical School
  • 55 Lake Avenue North
  • Worcester, MA 01655
  • United States
+1 (617)

Juniper Biomedical Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Juniper Biomedical Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Grant 20-Jan-2026 $1.6M Completed Product Development
10. Accelerator/Incubator 29-May-2024 Completed Product Development
9. Accelerator/Incubator 19-Apr-2024 Completed Product Development
8. Grant 02-Apr-2024 Completed Product Development
7. Seed Round 02-Apr-2024 Completed Product Development
6. Grant 01-Feb-2024 Completed Product Development
5. Seed Round 25-Apr-2023 Completed Product Development
4. Grant 12-Jul-2022 Completed Product Development
3. Accelerator/Incubator 10-Jun-2020 Completed Startup
2. Accelerator/Incubator 02-Jun-2020 Completed Startup
To view Juniper Biomedical’s complete valuation and funding history, request access »

Juniper Biomedical Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Seed-5
Seed-4
Seed-3
Seed-2 302,564 $0.000100 $0.61 $0.61 1x $0.61 5.52%
Seed-1 187,616 $0.000100 $0.53 $0.53 1x $0.53 3.42%
To view Juniper Biomedical’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Juniper Biomedical Patents

  • 21

    Total Documents Applications and Grants

  • Total Patents Families

  • 1

    Granted

  • 17

    Pending

  • Expiring in next 12 mo

Juniper Biomedical Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-12734360-B1 Systems and methods for selective peripheral nerve regeneration and remyelination Active 03-Dec-2025
AU-2025257866-A1 System and method for nerve stimulation, closed-loop feedback, and pelvic organ prolapse Pending 15-Apr-2024
US-20250332421-A1 System and method for nerve stimulation, closed-loop feedback, and pelvic organ prolapse Pending 15-Apr-2024
WO-2025221823-A1 System and method for nerve stimulation, closed-loop feedback, and pelvic organ prolapse Pending 15-Apr-2024
AU-2023309474-A1 System and method for nerve stimulation Pending 22-Jul-2022 A61N1/0558
To view Juniper Biomedical’s complete patent history, request access »

Juniper Biomedical Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Juniper Biomedical Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds
MedTech Innovator Accelerator/Incubator
Innovation Nexus Accelerator/Incubator
ATMA Capital Venture Capital Minority
Auroral Holdings Family Office Minority
Beacon Angels Angel Group Minority
You’re viewing 5 of 10 investors. Get the full list »

Ready to get started?

Request a free trial

Juniper Biomedical FAQs

  • When was Juniper Biomedical founded?

    Juniper Biomedical was founded in 2019.

  • Where is Juniper Biomedical headquartered?

    Juniper Biomedical is headquartered in Worcester, MA.

  • What is the size of Juniper Biomedical?

    Juniper Biomedical has 2 total employees.

  • What industry is Juniper Biomedical in?

    Juniper Biomedical’s primary industry is Therapeutic Devices.

  • Is Juniper Biomedical a private or public company?

    Juniper Biomedical is a Private company.

  • What is Juniper Biomedical’s current revenue?

    The current revenue for Juniper Biomedical is .

  • How much funding has Juniper Biomedical raised over time?

    Juniper Biomedical has raised $3.2M.

  • Who are Juniper Biomedical’s investors?

    MedTech Innovator, Innovation Nexus, ATMA Capital, Auroral Holdings, and Beacon Angels are 5 of 10 investors who have invested in Juniper Biomedical.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process